Pfizer buys 5 percent stake in Medarex BOSTON (CBS.MW) - Pharmaceutical powerhouse Pfizer is buying a 5 percent stake in biotechnology researcher Medarex under their newly signed collaboration deal, according to Medarex Chief Executive Donald Drakeman.